- Home
- SNX vs ICLR Comparison
SNX vs ICLR Comparison
Compare SNX & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNX
- ICLR
- Stock Information
- Founded
- SNX 1980
- ICLR 1990
- Country
- SNX United States
- ICLR Ireland
- Employees
- SNX N/A
- ICLR N/A
- Industry
- SNX Retail: Computer Software & Peripheral Equipment
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SNX Technology
- ICLR Health Care
- Exchange
- SNX Nasdaq
- ICLR Nasdaq
- Market Cap
- SNX 11.7B
- ICLR 13.7B
- IPO Year
- SNX 2003
- ICLR 1998
- Fundamental
- Price
- SNX $151.64
- ICLR $175.00
- Analyst Decision
- SNX Strong Buy
- ICLR Buy
- Analyst Count
- SNX 10
- ICLR 15
- Target Price
- SNX $149.80
- ICLR $209.93
- AVG Volume (30 Days)
- SNX 550.0K
- ICLR 1.0M
- Earning Date
- SNX 09-25-2025
- ICLR 10-22-2025
- Dividend Yield
- SNX 1.16%
- ICLR N/A
- EPS Growth
- SNX 19.95
- ICLR 13.11
- EPS
- SNX 8.55
- ICLR 9.73
- Revenue
- SNX $60,007,297,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- SNX $4.71
- ICLR N/A
- Revenue Next Year
- SNX $4.14
- ICLR $1.73
- P/E Ratio
- SNX $17.73
- ICLR $17.98
- Revenue Growth
- SNX 6.60
- ICLR N/A
- 52 Week Low
- SNX $92.23
- ICLR $125.10
- 52 Week High
- SNX $153.70
- ICLR $310.54
- Technical
- Relative Strength Index (RSI)
- SNX 59.89
- ICLR 53.09
- Support Level
- SNX $148.92
- ICLR $164.00
- Resistance Level
- SNX $153.06
- ICLR $180.95
- Average True Range (ATR)
- SNX 2.10
- ICLR 6.38
- MACD
- SNX 0.12
- ICLR -0.99
- Stochastic Oscillator
- SNX 81.75
- ICLR 64.59
About SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.